Schedule these treatments during eating windows when your skin is likely to be less sensitive and better able to recover
[31] Is the drug compatible with normal saline
The SUSTAIN 29,30,31,32,33,34,35 and SCALE studies 10,11,12,13,14,15 have shown robust efficacy in lowering blood glucose levels in diabetic patients and inducing weight loss in obese patients over clinical trial periods ranging from 30 to 104 weeks
It should not be interpreted as preparation guidance, administration guidance, injection guidance or personal-use instruction
Research from the New England Journal of Medicine found that continued GLP-1 therapy maintains weight loss rather than accelerating it further, which is why strategic intervention becomes important